CNS & Neurological Disorders - Drug Targets
Title:A Legend in Neuroscience (1948-2018) Dr. Stephen D. Skaper, Ph. D
Volume: 17 Issue: 5
Author(s):
Affiliation:
Export Options
About this article
Cite this article as:
, A Legend in Neuroscience (1948-2018) Dr. Stephen D. Skaper, Ph. D, CNS & Neurological Disorders - Drug Targets 2018; 17 (5) . https://dx.doi.org/10.2174/187152731705180807144306
DOI https://dx.doi.org/10.2174/187152731705180807144306 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
28
2
2
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications
Current Neuropharmacology Parvalbumin as a Pleomorphic Protein
Current Protein & Peptide Science Nanoparticle Delivery of Transition-Metal Chelators to the Brain: Oxidative Stress will Never See it Coming!
CNS & Neurological Disorders - Drug Targets Blind Snipers: Relevant Off Target Effects of Non-chemotherapeutic Agents in Oncology: Review of the Literature
Reviews on Recent Clinical Trials B Cell Modulation Strategies in Autoimmunity: The SLE Example
Current Pharmaceutical Design Chronic Deposition of Aβ Influences Microcirculation in the Chronic Stage of Cerebral Ischemia
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Implications of Parkinson’s Disease Pathophysiology for the Development of Cell Replacement Strategies and Drug Discovery in Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Structure-Activity Relationship Within the Serine Protease Inhibitors of the Pacifastin Family
Protein & Peptide Letters Ganglioside Mimicry as a Cause of Guillain-Barre Syndrome
CNS & Neurological Disorders - Drug Targets An Overview of Nanoformulated Nutraceuticals and their Therapeutic Approaches
Current Nutrition & Food Science Conspectus of Phytoconstituents and Pharmacological Activities of <i>Barleria lupulina</i> Lindl.: A Review
Current Traditional Medicine Racial/Ethnic Differences in Symptoms of Posttraumatic Stress Disorder
Current Psychiatry Reviews Medicinal Chemical and Pharmacological Aspects of Imidazole-Containing Histamine H3 Receptor Antagonists
Mini-Reviews in Medicinal Chemistry The Pathogenic Mechanisms of Prion Diseases
CNS & Neurological Disorders - Drug Targets The Recognition of 27-Class Protein Folds: Approached by Increment of Diversity Based on Multi-Characteristic Parameters
Protein & Peptide Letters Myogenic Potential of Mesenchymal Stem Cells - the Case of Adhesive Fraction of Human Umbilical Cord Blood Cells
Current Stem Cell Research & Therapy Sensitive HPLC Determination of Duloxetine after Extraction Using Magnetic Multi-walled Carbon Nanotubes
Current Analytical Chemistry Growth Factor Changes in Cerebrospinal Fluid of Children with Mental Retardation before and after Neural Precursor Cell Transplantation
CNS & Neurological Disorders - Drug Targets Immunotherapy with Peptides in Systemic Lupus Erythematosus
Current Medicinal Chemistry Therapeutic Strategies To Prevent Neurodegeneration And Promote Regeneration In Multiple Sclerosis
Current Drug Targets - Immune, Endocrine & Metabolic Disorders